Clinical studies recruiting near Augsburg

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · University Hospital Augsburg · Joseph Broderick, MD · NCT07227246 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Universitätsklinikum Augsburg · Princess Maxima Center for Pediatric Oncology · NCT05327894 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 6416 · Galderma R&D · NCT06988605 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Universitatsklinikum Augsburg · Miltenyi Biomedicine GmbH · NCT04844866 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Klinikum Augsburg · AGO Study Group · NCT05009082 A Non-interventional, Prospective Study With Benralizumab
Phase N/A · Research Site · AstraZeneca · NCT06422078 REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)
Phase N/A · Klinik für Diagnostische Radiologie und Neuroradiologie; Uni · Acandis GmbH · NCT05345483 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Universitätsklinikum Augsburg · PedAL BCU, LLC · NCT05183035 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07549516 Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
Phase N/A · Klinik für Strahlentherapie · University of Erlangen-Nürnberg Medical School · NCT07131956 Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib +
Phase N/A · Research Site · AstraZeneca · NCT06380738 Endometrial Cancer Lymphadenectomy Trial
NA · Universitätsklinikum Augsburg, Frauenklinik · Philipps University Marburg · NCT03438474 Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic
Phase N/A · Department of Urology, University Hosptial Augsburg · Comprehensive Cancer Center Munich (CCCM) · NCT06657157 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 International HIT-MED Registry (I-HIT-MED)
Phase N/A · Klinikum Augsburg · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
Phase N/A · HOP Gemeinschaftspraxis Dres. Heinrich/Bangerter, Augsburg · Women's Cancer Study Group GmbH · NCT05792150 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Klinikum Augsburg · Goethe University · NCT02872987 Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)
NA · University Hospital Augsburg, Clinic for Pediatric Surgery · University of Leipzig · NCT03469609 Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)
Phase 2 · Universitätsklinikum Augsburg · German Cancer Research Center · NCT05332561 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Klinikum Augsburg · SAb Biotherapeutics, Inc. · NCT07187531 A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Phase N/A · Rheumapraxis Am Webereck /ID# 274412 · AbbVie · NCT06712628 Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
Phase 4 · Universitätsklinikum Augsburg; III. Med. Klinik · University of Leipzig · NCT05551299 Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06517719 Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
Phase 2 · Universitätsklinikum Augsburg · Technische Universität Dresden · NCT05904106 Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNS
Phase 3 · University Hospital Augsburg · University Hospital Freiburg · NCT06830421 Vyxeos® With Clofarabine for Pediatric AML
Phase 1 · Universitätsklinikum Augsburg · Princess Maxima Center for Pediatric Oncology · NCT07156435 The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subje
Phase 4 · Bezirkskliniken Schwaben, Bezirkskrankenhaus Augsburg · Dr. Inge Winter · NCT05958875 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720 Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
Phase 2 · Department of Radiation Oncology, University Hospital Augsbu · University Hospital Tuebingen · NCT05871021

Look up another city

Look up another condition